The US Food and Drug Administration should work with the US Patent and Trademark Office to verify information submitted for inclusion in the Orange Book is correct, a professor said at their joint public “listening session.”
S. Sean Tu, a professor at West Virginia University College of Law, focused on how the FDA and USPTO could deter creation of pharmaceutical patent thickets. He said continuation patents...